LEXICON
No.151 March 4, 2016

Market expansion re-pricing
市場拡大再算定

The basic principle of biennial drug price revisions is to update NHI reimbursement drug prices based on actual market prices, which are investigated through market price surveys/drug price surveys (薬価調査; yakka chosa ) prior to each revision. To curtail medical...

To read the full story

LEXICON

By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…

Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…